Florian Brand - Mar 14, 2024 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Co-Founder & Chief Executive Officer
Signature
/s/ Ryan Barrett , Attorney-in-fact
Stock symbol
ATAI
Transactions as of
Mar 14, 2024
Transactions value $
$0
Form type
4
Date filed
3/15/2024, 08:16 PM
Previous filing
Nov 20, 2023
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATAI Common Shares Options Exercise +350K +269.23% 480K Mar 14, 2024 Direct F1
holding ATAI Common Shares 2.33K Mar 14, 2024 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Restricted Stock Unit Options Exercise $0 -350K -50% $0.00 350K Mar 14, 2024 Common Shares 350K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date.

Remarks:

Co-Founder & Chief Executive Officer